ALTITUDE LIFE SCIENCE VENTURES — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Pulmatrixpulmatrix.comNASDAQ: PULMJun 2015 · $10M

Pulmatrix develops inhaled dry-powder therapies using its proprietary iSPERSE technology, which uses small, dense, dispersible particles to deliver respiratory and non-respiratory drugs via the respiratory system.

BiotechDeep TechHealthtechMedical DevicesFramingham, US

Anand Varadan(Director)inRichard Batycky(Director)Peter Ludlum(Interim Chief Executive Officer)Hojabr Alimi(Executive Officer)Sameer Harish(Executive Officer)

BoardRichard Conley(Director)

Co-investors5AM Ventures ARCH Venture Partners Polaris Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.